Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-14
DOI
10.3389/fonc.2022.898583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RNA-Sequencing Reveals Heat Shock 70-kDa Protein 6 (HSPA6) as a Novel Thymoquinone-Upregulated Gene That Inhibits Growth, Migration, and Invasion of Triple-Negative Breast Cancer Cells
- (2021) Shiyi Shen et al. Frontiers in Oncology
- The Role of Autophagy in Anti-Cancer and Health Promoting Effects of Cordycepin
- (2021) Yu-Ying Chen et al. MOLECULES
- Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update
- (2021) Anusha Govindula et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TQFL12, a novel synthetic derivative of TQ, inhibits triple‐negative breast cancer metastasis and invasion through activating AMPK/ACC pathway
- (2021) Chunli Wei et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Systematic Review of the Biological Effects of Cordycepin
- (2021) Masar Radhi et al. MOLECULES
- Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic Medicinal Fungus Cordyceps with Its Nutraceutical and Therapeutic Potential
- (2020) Syed Amir Ashraf et al. MOLECULES
- Pembrolizumab and atezolizumab in triple-negative breast cancer
- (2020) Dorota Kwapisz CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trends in the Immunomodulatory Effects of Cordyceps militaris: Total Extracts, Polysaccharides and Cordycepin
- (2020) Chun-Ting Lee et al. Frontiers in Pharmacology
- Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1
- (2017) Jun Li et al. MOLECULES
- Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
- (2017) Md. Asaduzzaman Khan et al. Oncotarget
- MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion
- (2017) Saber Imani et al. Oncotarget
- Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis
- (2015) Kazuki Nakamura et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition
- (2015) Md. Asaduzzaman Khan et al. Oncotarget
- Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
- (2014) Wen-Ling Yao et al. Anti-Cancer Agents in Medicinal Chemistry
- Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer
- (2014) Mousumi Tania et al. TUMOR BIOLOGY
- Twist: a molecular target in cancer therapeutics
- (2013) Md. Asaduzzaman Khan et al. TUMOR BIOLOGY
- Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways
- (2012) Ying-Yi Chen et al. PHYTOMEDICINE
- The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis
- (2010) Junjiang Fu et al. CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search